TAGLIAFERRI, PIEROSANDRO

TAGLIAFERRI, PIEROSANDRO  

Dipartimento di Medicina sperimentale e clinica  

Mostra records
Risultati 1 - 20 di 365 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
2 CLASSES OF CAMP ANALOGS SYNERGISTICALLY INHIBIT P21 RAS PROTEIN-SYNTHESIS AND PHENOTYPIC TRANSFORMATION OF NIH/3T3 CELLS TRANSFECTED WITH HA-MUSV DNA 1-gen-1985 Tagliaferri, P; Clair, T; Debortoli, Me; Chochung, Ys
5-AZA-2'-DEOXYCYTIDINE INDUCES GROWTH-INHIBITION AND UP-REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR ON HUMAN EPITHELIAL CANCER-CELLS 1-gen-1994 Caraglia, M; Pinto, A; Correale, P; Zagonel, V; Genua, G; Leardi, A; Pepe, S; Bianco, Ar; Tagliaferri, P
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor 1-gen-1999 Budillon, A; DI GENNARO, E; Caraglia, M; Barbarulo, D; Abbruzzese, A; Tagliaferri, P
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS 1-gen-1994 Rea, A; Palmieri, G; Tinari, N; Natoli, C; Tagliaferri, P; Morabito, A; Grassadonia, A; Bianco, Ar; Iacobelli, S
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 1-gen-2014 Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Amodio, N; Tassone, P
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 1-gen-2016 Gulla', A; Di Martino, Mt; Gallo Cantafio, Me; Morelli, E; Amodio, N; Botta, C; Pitari, Mr; Lio, Sg; Stamato, Ma; Hideshima, T; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P; Britti, Domenico
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation 1-gen-2008 Cascinu, S; Berardi, R; Salvagni, S; Beretta, Gd; Catalano, V; Pucci, F; Sobrero, A; Tagliaferri, P; Labianca, R; Scartozzi, M; Crocicchio, F; Mari, E; Ardizzoni, A
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 1-gen-2019 Catalano, R; Rocca, Roberta; Juli, Giada; Costa, Giosuè; Maruca, A; Artese, A; Caracciolo, D; Tagliaferri, P; Alcaro, S; Tassone, P; Amodio, N.
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival 1-gen-2016 Botta, C; Di Martino, Mt; Ciliberto, D; Cucè, M; Correale, P; Tagliaferri, P; Tassone, P; Rossi, M
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 1-gen-2022 Riillo, Caterina; Caracciolo, Daniele; Grillone, Katia; Polerà, Nicoletta; Tuccillo, Franca Maria; Bonelli, Patrizia; Juli, Giada; Ascrizzi, Serena; Scionti, Francesca; Arbitrio, Mariamena; Lopreiato, Mariangela; Siciliano, Maria Anna; Sestito, Simona; Talarico, Gabriella; Galea, Eulalia; Galati, Maria Concetta; Pensabene, Licia; Loprete, Giovanni; Rossi, Marco; Ballerini, Andrea; Gentile, Massimo; Britti, Domenico; Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 1-gen-2014 Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Di Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Tassone, P; Amodio, N
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 1-gen-2014 Leotta, Marzia; Biamonte, Lavinia; Raimondi, Lavinia; Ronchetti, Domenica; Di Martino, Maria Teresa; Botta, Cirino; Leone, Emanuela; Pitari, Maria Rita; Neri, Antonino; Giordano, Antonio; Tagliaferri, Pierosandro; Tassone, Pierfrancesco; Amodio, Nicola
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 1-gen-2011 Di Martino Maria, T.; Arbitrio, Mariamena; Guzzi Pietro, H.; Leone, Emanuela; Baudi, Francesco; Piro, Eugenio; Prantera, Tullia; Cucinotto, Iole; Calimeri, Teresa; Rossi, Marco; Veltri, Pierangelo; Cannataro, Mario; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
A PH-DEPENDENT DIFFERENTIAL CYTO-TOXICITY OF OUABAIN FOR HUMAN-CELLS TRANSFORMED BY CERTAIN ONCOGENES 1-gen-1988 Talbot, N; Tagliaferri, P; Yanagihara, K; Rhim, Js; Bassin, Rh; Benade, Le
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 1-gen-2006 Valerio, Mr; Tagliaferri, P; Raspagliesi, F; Fulfaro, F; Badalamenti, G; Arcara, C; Cicero, G; Russo, A; Venuta, S; Guarneri, G; Gebbia, N
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 1-gen-2022 Staropoli, N.; Arbitrio, M.; Salvino, A.; Scionti, F.; Ciliberto, D.; Ingargiola, R.; Labanca, C.; Agapito, G.; Iuliano, E.; Barbieri, V.; Cuce, M.; Zuccala, V.; Cannataro, M.; Tassone, P.; Tagliaferri, P.
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 1-gen-2023 Riillo, Caterina; Polerà, Nicoletta; Di Martino, Maria Teresa; Juli, Giada; Hokanson, Craig A; Odineca, Tatjana; Signorelli, Stefania; Grillone, Katia; Ascrizzi, Serena; Mancuso, Antonia; Staropoli, Nicoletta; Caparello, Basilio; Cerra, Maria; Nisticò, Giuseppe; Tagliaferri, Pierosandro; Crea, Roberto; Caracciolo, Daniele; Tassone, Pierfrancesco
A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: A focus on the quality of life 1-gen-2005 Zullo, F; Palomba, S; Russo, T; Falbo, A; Costantino, M; Tolino, A; Zupi, E; Tagliaferri, P; Venuta, S
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it? 1-gen-2013 Staropoli, Nicoletta; Ciliberto, Domenico; Botta, Cirino; Fiorillo, Lucia; Gualtieri, Simona; Salvino, Angela; Tagliaferri, P; Tassone, P
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? 1-gen-2015 Ciliberto, D; Staropoli, N; Caglioti, F; Gualtieri, S; Fiorillo, L; Chiellino, S; De Angelis, Am; Mendicino, F; Botta, C; Caraglia, M; Tagliaferri, P; Tassone, P